van den Eijnden D H, Bergh M L, Dieleman B, Schiphorst W E
Hoppe Seylers Z Physiol Chem. 1981 Feb;362(2):113-24. doi: 10.1515/bchm2.1981.362.1.113.
Ovine submaxillary asialo-mucin was [14C]sialylated in vitro using a porcine liver cell-free preparation. The oligosaccharide chains were cleaved from the product glycoprotein by beta-elimination under reductive conditions, fractionated by gel filtration on Bio-Gel P-2 and characterized by thin-layer chromatography. The structure of the product chain was studied by periodate oxidation and analysis of the peeling products formed in the beta-elimination step. It appeared that [14C]-sialic acid had been introduced exclusively to the galactose residues of Gal beta(1 leads to 3)GalNAc disaccharide units occurring on the mucin as minor chains. No indication for a transfer to GalNAc residues on this glycoprotein was obtained. In agreement with this result sialyltransferase activities of porcine, rat, human and canine liver with Gal beta (1 leads to 3)GalNAc-protein acceptors were invariably much higher than those with ovine submaxillary asialo-mucin. When the asialo-mucin had been [14C]sialylated by an ovine submaxillary gland cell-free preparation analysis of the product oligosaccharide chain revealed the introduction of [14C]sialic acid to position C-6 on the GalNAc residues. The specificity of this transfer was reflected by the very high sialyltransferase activities of gland preparations with Gal beta (1 leads to 3)GalNAc-protein as well as GalNAc-protein acceptors. Mixed enzyme experiments indicated that the difference in liver and gland ovine submaxillary asialo-mucin sialyltransferase activities was not due to the presence of a specific inhibitor in the liver or an activator in the gland. It is concluded that porcine liver and likely liver of rat, man and dog contains a Gal beta (1 leads to 3)GalNAc-protein sialyltransferase, which is involved in the sialylation of O-glycosidically linked carbohydrate chains on serum glycoproteins. GalNAc-protein sialyltransferase activity, which richly occurs in ovine submaxillary gland, however, appears to be lacking from liver tissue.
使用猪肝无细胞制剂在体外对绵羊颌下腺去唾液酸粘蛋白进行[14C]唾液酸化。在还原条件下通过β-消除从产物糖蛋白上切割下寡糖链,通过Bio-Gel P-2凝胶过滤进行分级分离,并通过薄层色谱进行表征。通过高碘酸盐氧化和分析β-消除步骤中形成的剥离产物来研究产物链的结构。结果表明,[14C] - 唾液酸仅被引入到作为小链存在于粘蛋白上的Galβ(1→3)GalNAc二糖单元的半乳糖残基上。未获得向该糖蛋白上的GalNAc残基转移的迹象。与该结果一致,猪、大鼠、人及犬肝中针对Galβ(1→3)GalNAc - 蛋白受体的唾液酸转移酶活性始终远高于针对绵羊颌下腺去唾液酸粘蛋白的活性。当去唾液酸粘蛋白通过绵羊颌下腺无细胞制剂进行[14C]唾液酸化时,对产物寡糖链的分析显示[14C] - 唾液酸被引入到GalNAc残基的C - 6位。这种转移的特异性通过腺体制剂针对Galβ(1→3)GalNAc - 蛋白以及GalNAc - 蛋白受体的非常高的唾液酸转移酶活性得以体现。混合酶实验表明,肝和绵羊颌下腺去唾液酸粘蛋白唾液酸转移酶活性的差异并非由于肝中存在特异性抑制剂或腺体中存在激活剂。得出的结论是,猪肝以及可能大鼠、人及犬的肝中含有一种Galβ(1→3)GalNAc - 蛋白唾液酸转移酶,其参与血清糖蛋白上O - 糖苷键连接的碳水化合物链的唾液酸化。然而,在肝组织中似乎缺乏大量存在于绵羊颌下腺中的GalNAc - 蛋白唾液酸转移酶活性。